Group Leader
The aim of the team is to understand the transcriptional and epigenetic mechanisms that control the immunoglobulin heavy chain locus along B-cell development, and the role of the RAG complex and AID in B-cell acute lymphoblastic leukemia.
The major goal of our team is to decipher the molecular mechanisms underlying antibody diversity and B-cell cancers.
By using a combination of genetic, functional and mechanistic analyses, we investigate the molecular mechanisms that control antibody diversity and the role of specific enzymes in B-cell acute lymphoblastic leukemia.
Developing B lymphocytes have a remarkable capacity to somatically alter their genome through V(D)J recombination at the variable regions of their loci. This process is catalyzed by the RAG1/2 complex. Mature B cells have the unique ability to undergo an additional recombination process called class switch recombination (CSR), initiated by the enzyme AID (Activation-Induced cytidine Deaminase), which targets highly repetitive sequences within the constant genes of the immunoglobulin heavy chain (IgH) locus.
Both V(D)J recombination and CSR are controlled by distant regulatory elements on the chromosome. These include promoters, enhancers and insulators, which engage in long-range interactions in a developmental stage-specific manner.
Our aim is to understand the transcriptional and epigenetic mechanisms that control these interactions in vivo and how the cross-talk between IgH regulatory elements regulates IgH locus expression along B-cell development.
B-cell acute lymphoblastic leukemia (B-ALL) is the most frequent pediatric cancer. This neoplasm of early B cells is a multi-step disease featuring diverse genetic alterations. We have previously generated a mouse model which mimics the multistep leukemogenesis process of human B-ALL.
By using this model, our objective is to understand the role of the RAG complex and AID in the onset of B-ALL.
Ahmed Amine Khamlichi (CNRS)
Audrey Dauba (University)
Kawtar Hanefioui
Oudinet et al. (2022) Switch Tandem Repeats Influence the Choice of the Alternative End-Joining Pathway in Immunoglobulin Class Switch Recombination. Front Immunol
Dauba et al. (2021) Interleukin 7 regulates switch transcription in developing B cells. Cell Mol Immunol
Oudinet et al. (2020) Recombination may occur in the absence of transcription in the immunoglobulin heavy chain recombination centre. Nucleic Acids Res
Santos et al. (2019) Two modes of cis-activation of switch transcription by the IgH superenhancer. Proc Natl Acad Sci USA
Oudinet et al (2019) Developmental regulation of DNA cytosine methylation at the immunoglobulin heavy chain constant locus. PLoS Genet
Jamrog*, Chemin* et al. (2018) PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice. Proc Natl Acad Sci USA
We are grateful to our past and present national and international collaborators:
Prizes
June 2021 – Dr Chloé Oudinet is awarded the Toulouse Academy of sciences prize for her PhD work.
Press Releases
The complete list of our publications is available through Pubmed.
Oudinet, C., Braikia, F.Z., Dauba, A., Khamlichi, A.A. (2020) Recombination may occur in the absence of transcription in the immunoglobulin heavy chain recombination centre. Nucleic Acids Res 48, 3553-3566
Oudinet, C., Braikia, F.Z., Dauba, A., Santos, J.M., Khamlichi, A.A. (2019) Developmental regulation of DNA cytosine methylation at the immunoglobulin heavy chain constant locus. PLoS Genet 15, e1007930
Samara, M., Oruc, Z., Dougier, H.L., Essawi, T., Cogne, M., Khamlichi, A.A. (2006) Germ line transcription in mice bearing neor gene downstream of Igamma3 exon in the Ig heavy chain locus. Int Immunol 18, 581-589
We are indebted to former PhD students and post-doctoral fellows who are now continuing their career in the best labs, enterprises and institutions :